Clinical Trials Directory

Trials / Completed

CompletedNCT00964769

Study of Evaluation Indexes for Antibody Production in Sera After Immunization

A Study of Evaluation Indexes for Antibody Production in Sera After Immunization

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Ewha Womans University · Academic / Other
Sex
All
Age
2 Years – 90 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate analytical methods such as ELISA and OPKA that measure the activity of vaccine-induced pneumococcal antibodies. After validation of ELISA and OPKA, pneumococcal antibodies were measured by ELISA and OPKA in paired samples before and after immunization (pneumococcal PS vaccine) in children, adults and elderly.

Detailed description

To evaluate the immune response to the pneumococcal polysaccharide vaccine in the elderly, samples from children, young adults and elderly were obtained before and one month after vaccination. The quantitative and qualitative response to the vaccine were measured by the ELISA and opsonophagocytic killing assay for eight vaccine type serotypes (4, 6B, 9V, 14, 18C, 19A, 19F, 23F) and one vaccine-related serotype (6A).

Conditions

Interventions

TypeNameDescription
BIOLOGICALpneumococcal polysaccharide vaccinesingle intramuscular injection of 0.5 ml Pneumo23® (Sanofi-Aventis, Lyon France)

Timeline

Start date
2005-04-01
Primary completion
2005-05-01
Completion
2005-06-01
First posted
2009-08-25
Last updated
2009-08-25

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00964769. Inclusion in this directory is not an endorsement.